Literature DB >> 8175149

The fate of intravenously injected endotoxin in normal rats and in rats with liver failure.

A Nakao1, S Taki, M Yasui, Y Kimura, T Nonami, A Harada, H Takagi.   

Abstract

The elimination of endotoxin from the blood was studied in rats with D-galactosamine-induced liver failure and in normal controls after intravenous injection of various doses of endotoxin. Endotoxin was found to localize in liver tissue by immunohistochemical staining with factor C, which is derived from amebocyte lysate of the horseshoe crab and which reacts specifically with endotoxin. Before injection, the blood endotoxin concentrations were normal both in control rats and in rats with liver failure. The blood concentrations of endotoxin were significantly higher after intravenous injection of endotoxin in the D-galactosamine-induced liver failure group (p < 0.05) and decreased much more slowly (p < 0.05). Endotoxin concentrations were also significantly higher after in vitro incubation with plasma from rats with liver failure (p < 0.05). After intravenous injection of endotoxin (1 mg/kg), endothelial and Kupffer cells in the liver sinusoids were positively stained for endotoxin in the control group, but not stained or faintly stained in the liver failure group. Endotoxemia in liver failure thus results from reduced inactivation of endotoxin in plasma and from impaired hepatic clearance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175149

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

Review 1.  Animal models of acute hepatic failure.

Authors:  T M Rahman; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Effect of hepatocyte apoptosis induced by TNF-alpha on acute severe hepatitis in mouse models.

Authors:  Guo-Qing Zang; Xia-Qiu Zhou; Hong Yu; Qing Xie; Guo-Ming Zhao; Bin Wang; Qing Guo; Yue-Qin Xiang; Dan Liao
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

3.  Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes.

Authors:  Baomei Shao; Robert S Munford; Richard Kitchens; Alan W Varley
Journal:  Innate Immun       Date:  2012-03-22       Impact factor: 2.680

4.  Plasma (1-->3)-beta-D-glucan assay and immunohistochemical staining of (1-->3)-beta-D-glucan in the fungal cell walls using a novel horseshoe crab protein (T-GBP) that specifically binds to (1-->3)-beta-D-glucan.

Authors:  H Tamura; S Tanaka; T Ikeda; T Obayashi; Y Hashimoto
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

5.  An insight into the possible protective effect of pyrrolidine dithiocarbamate against lipopolysaccharide-induced oxidative stress and acute hepatic injury in rats.

Authors:  Hanan H Hagar
Journal:  Saudi Pharm J       Date:  2009-11-10       Impact factor: 4.330

6.  Changes of gut flora and endotoxin in rats with D-galactosamine-induced acute liver failure.

Authors:  Lan-Juan Li; Zhong-Wen Wu; Dang-Sheng Xiao; Ji-Fang Sheng
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

7.  Movement-evoked hyperalgesia induced by lipopolysaccharides is not suppressed by glucocorticoids.

Authors:  Katalin J Kovács; Jonathan C Papic; Alice A Larson
Journal:  Pain       Date:  2007-08-07       Impact factor: 6.961

Review 8.  Innate immune dysfunction in acute and chronic liver disease.

Authors:  Bettina Leber; Ursula Mayrhauser; Michael Rybczynski; Vanessa Stadlbauer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

9.  Uptake of bacterial lipopolysaccharide and expression of tumor necrosis factor-α-mRNA in isolated rat intrahepatic bile duct epithelial cells.

Authors:  X M Chen; D W Han; K Noguchi; K Tanikawa
Journal:  World J Gastroenterol       Date:  1997-03-15       Impact factor: 5.742

10.  Dynamic changes of lipopolysaccharide levels in different phases of acute on chronic hepatitis B liver failure.

Authors:  Calvin Pan; Yurong Gu; Wei Zhang; Yubao Zheng; Liang Peng; Hong Deng; Youming Chen; Lubiao Chen; Sui Chen; Min Zhang; Zhiliang Gao
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.